McKesson Corporation $MCK Shares Sold by Paralel Advisors LLC

Posted by Geri Gentry on Sep 7th, 2026

Paralel Advisors LLC lowered its stake in McKesson Corporation (NYSE:MCK – Free Report) by 32.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 2,670 shares of the company’s stock after selling 1,305 shares during the period. Paralel Advisors LLC’s holdings in McKesson were worth $2,017,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. BlackRock Inc. acquired a new position in shares of McKesson in the 2nd quarter worth approximately $8,156,743,000. Norges Bank acquired a new stake in shares of McKesson during the 4th quarter valued at approximately $1,651,137,000. Bank of America Corp DE acquired a new stake in shares of McKesson during the 2nd quarter valued at approximately $998,896,000. Legal & General Group Plc bought a new position in McKesson during the second quarter worth $656,566,000. Finally, The Manufacturers Life Insurance Company acquired a new position in McKesson in the second quarter worth $651,462,000. Institutional investors and hedge funds own 85.07% of the company’s stock.

Analyst Ratings Changes

MCK has been the subject of several recent research reports. TD Cowen boosted their target price on shares of McKesson from $989.00 to $1,006.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Wells Fargo & Company raised their price target on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 11th. Evercore restated an “outperform” rating on shares of McKesson in a research report on Thursday, August 6th. Finally, Citigroup upped their price objective on McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Friday, July 24th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, McKesson has an average rating of “Moderate Buy” and a consensus target price of $973.44.

Get Our Latest Report on McKesson

Insiders Place Their Bets

In other McKesson news, Director Bradley Lerman sold 301 shares of the business’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $892.33, for a total transaction of $268,591.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Brian Tyler sold 8,463 shares of the firm’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total value of $6,715,898.28. Following the transaction, the chief executive officer directly owned 5,919 shares in the company, valued at $4,697,081.64. This trade represents a 58.84% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 22,156 shares of company stock valued at $17,305,242 in the last quarter. 0.06% of the stock is currently owned by insiders.

McKesson Trading Down 0.1%

NYSE MCK opened at $907.35 on Monday. The company has a 50-day moving average price of $848.13 and a two-hundred day moving average price of $842.45. McKesson Corporation has a 52 week low of $682.35 and a 52 week high of $999.00. The stock has a market cap of $105.79 billion, a price-to-earnings ratio of 24.28, a price-to-earnings-growth ratio of 1.81 and a beta of 0.30.

McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 earnings per share for the quarter, beating analysts’ consensus estimates of $9.56 by $0.37. The company had revenue of $105.38 billion for the quarter, compared to analysts’ expectations of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $8.26 earnings per share. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. As a group, equities research analysts expect that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.94 per share. This represents a $3.76 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 1st. This is an increase from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio (DPR) is presently 10.06%.

McKesson Profile

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.